LeMaitre Vascular Return on Tangible Equity 2010-2025 | LMAT
Current and historical return on tangible equity values for LeMaitre Vascular (LMAT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| LeMaitre Vascular Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.05B | $0.25B | 19.44% |
| 2024-12-31 | $0.04B | $0.24B | 19.98% |
| 2024-09-30 | $0.04B | $0.23B | 19.64% |
| 2024-06-30 | $0.04B | $0.22B | 19.34% |
| 2024-03-31 | $0.03B | $0.20B | 18.26% |
| 2023-12-31 | $0.03B | $0.19B | 17.00% |
| 2023-09-30 | $0.03B | $0.18B | 16.67% |
| 2023-06-30 | $0.03B | $0.17B | 15.63% |
| 2023-03-31 | $0.02B | $0.16B | 13.82% |
| 2022-12-31 | $0.02B | $0.16B | 14.33% |
| 2022-09-30 | $0.02B | $0.15B | 14.87% |
| 2022-06-30 | $0.02B | $0.14B | 16.82% |
| 2022-03-31 | $0.03B | $0.14B | 23.03% |
| 2021-12-31 | $0.03B | $0.14B | 28.27% |
| 2021-09-30 | $0.03B | $0.13B | 37.97% |
| 2021-06-30 | $0.03B | $0.06B | 58.00% |
| 2021-03-31 | $0.03B | $0.05B | 62.89% |
| 2020-12-31 | $0.02B | $0.05B | 46.32% |
| 2020-09-30 | $0.02B | $0.03B | 35.56% |
| 2020-06-30 | $0.02B | $0.02B | 23.94% |
| 2020-03-31 | $0.02B | $0.09B | 20.22% |
| 2019-12-31 | $0.02B | $0.08B | 21.05% |
| 2019-09-30 | $0.02B | $0.09B | 21.92% |
| 2019-06-30 | $0.02B | $0.10B | 21.47% |
| 2019-03-31 | $0.02B | $0.09B | 26.36% |
| 2018-12-31 | $0.02B | $0.09B | 26.98% |
| 2018-09-30 | $0.02B | $0.08B | 25.30% |
| 2018-06-30 | $0.02B | $0.09B | 27.16% |
| 2018-03-31 | $0.02B | $0.08B | 24.00% |
| 2017-12-31 | $0.02B | $0.08B | 24.64% |
| 2017-09-30 | $0.02B | $0.07B | 25.40% |
| 2017-06-30 | $0.01B | $0.07B | 23.24% |
| 2017-03-31 | $0.01B | $0.06B | 20.60% |
| 2016-12-31 | $0.01B | $0.05B | 19.05% |
| 2016-09-30 | $0.01B | $0.06B | 19.05% |
| 2016-06-30 | $0.01B | $0.06B | 18.35% |
| 2016-03-31 | $0.01B | $0.06B | 17.48% |
| 2015-12-31 | $0.01B | $0.05B | 16.49% |
| 2015-09-30 | $0.01B | $0.05B | 15.22% |
| 2015-06-30 | $0.01B | $0.05B | 13.64% |
| 2015-03-31 | $0.01B | $0.04B | 11.24% |
| 2014-12-31 | $0.00B | $0.04B | 9.47% |
| 2014-09-30 | $0.00B | $0.04B | 7.50% |
| 2014-06-30 | $0.00B | $0.05B | 7.89% |
| 2014-03-31 | $0.00B | $0.04B | 8.57% |
| 2013-12-31 | $0.00B | $0.04B | 11.43% |
| 2013-09-30 | $0.00B | $0.03B | 11.51% |
| 2013-06-30 | $0.00B | $0.04B | 11.19% |
| 2013-03-31 | $0.00B | $0.04B | 11.11% |
| 2012-12-31 | $0.00B | $0.03B | 8.22% |
| 2012-09-30 | $0.00B | $0.04B | 5.37% |
| 2012-06-30 | $0.00B | $0.04B | 5.41% |
| 2012-03-31 | $0.00B | $0.04B | 5.41% |
| 2011-12-31 | $0.00B | $0.04B | 5.41% |
| 2011-09-30 | $0.00B | $0.04B | 10.81% |
| 2011-06-30 | $0.01B | $0.04B | 13.42% |
| 2011-03-31 | $0.01B | $0.04B | 16.33% |
| 2010-12-31 | $0.01B | $0.04B | 19.44% |
| 2010-09-30 | $0.01B | $0.04B | 17.02% |
| 2010-06-30 | $0.01B | $0.04B | 14.71% |
| 2010-03-31 | $0.00B | $0.03B | 12.12% |
| 2009-12-31 | $0.00B | $0.03B | 3.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.839B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.440B | 27.47 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $143.752B | 30.06 |
| EssilorLuxottica (ESLOY) | France | $130.179B | 0.00 |
| Medtronic (MDT) | Ireland | $103.476B | 14.67 |
| Haleon (HLN) | United Kingdom | $50.205B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.251B | 0.00 |
| ResMed (RMD) | United States | $35.607B | 26.74 |
| GE HealthCare Technologies (GEHC) | United States | $31.667B | 15.03 |
| Agilent Technologies (A) | United States | $30.942B | 20.44 |
| Terumo (TRUMY) | Japan | $27.686B | 35.96 |
| Insulet (PODD) | United States | $22.616B | 88.77 |
| Koninklijke Philips (PHG) | Netherlands | $21.196B | 15.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.329B | 11.77 |
| Baxter (BAX) | United States | $15.457B | 11.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.090B | 21.19 |
| Lantheus Holdings (LNTH) | United States | $5.110B | 12.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.237B | 18.93 |
| Perrigo (PRGO) | Ireland | $3.651B | 9.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| Haemonetics (HAE) | United States | $3.173B | 14.46 |
| Envista Holdings (NVST) | United States | $2.834B | 23.55 |
| GN Store Nord (GNNDY) | Denmark | $2.054B | 17.01 |
| QuidelOrtho (QDEL) | United States | $2.011B | 13.83 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.315B | 16.83 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.185B | 12.03 |
| Green Thumb Industries (GTBIF) | United States | $1.145B | 25.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.035B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.04 |
| InMode (INMD) | Israel | $0.899B | 9.06 |
| Evolus (EOLS) | United States | $0.624B | 0.00 |
| CeriBell (CBLL) | United States | $0.599B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.569B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Owens & Minor (OMI) | United States | $0.498B | 4.13 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Surmodics (SRDX) | United States | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 55.00 |
| Sanara MedTech (SMTI) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.231B | 10.48 |
| Brainsway (BWAY) | Israel | $0.203B | 53.65 |
| Biote (BTMD) | United States | $0.201B | 5.66 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.22 |
| Exagen (XGN) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.86 |
| Jin Medical (ZJYL) | China | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.71 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |